This was highlighted by the regulation of TREM1, neuroinflammation, and cellular senescence/inflammatory pathways present in all groups and further established by the widespread microglial activation seen in AD and SARS-CoV-2-infected AD cases, and in particular, the nodular formation seen in SARS-CoV-2-infected AD cases. This evidence concerns the gene TREM1 and Alzheimer disease.